Arcturus Therapeutics In...

NASDAQ: ARCT · Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.17
-1.62%
After-hours: Aug 15, 2025, 07:54 PM EDT

Arcturus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-60.16M -68.2M -80.94M -59.51M -68.83M -104.16M -26.59M 99.33M 80.28M 111.27M 9.35M -146.66M -165.48M -198.5M -203.67M -196.12M -163.03M -118.72M
Depreciation & Amortization
3.31M 3.44M 3.54M 3.54M 3.46M 3.28M 2.96M 2.69M 2.28M 1.88M 1.53M 1.29M 1.16M 1.11M 1.19M 1.15M 1.08M 1.01M
Stock-Based Compensation
31.34M 34.56M 37.99M 37.82M 37.6M 36.55M 34.65M 32.36M 32.53M 31.42M 30.61M 31.6M 29.03M 29.3M 28.91M 24.22M 19.34M 12.9M
Other Working Capital
2.94M -28.19M -9.91M -3.34M -17.42M 28.34M 42.84M 82.83M 46.96M 4.57M -17.51M -63.58M 1.49M 27.92M 32.79M 46.77M 7.14M 7.34M
Other Non-Cash Items
-44.29M -40.46M -40.43M -34.69M 5.83M -67.75M -101.1M -105.04M -105.05M -30.25M 4.18M 3.46M 4.44M 3.83M 8.38M 6.61M 6.09M 5.58M
Deferred Income Tax
n/a n/a n/a -16.7M -16.7M 56.6M 56.6M 73.3M 73.3M n/a n/a 501K 245K 596K -1.09M -1.59M -1.34M -1.59M
Change in Working Capital
4.87M -18.67M 20.09M 9.54M -29.99M 87.78M 15.47M 40.14M 49.43M -68.04M -12.56M -59.83M -13.28M 22.53M 31.23M 66.54M 39.46M 26.86M
Operating Cash Flow
-64.94M -89.33M -59.75M -60.01M -68.65M 12.3M -18.01M 142.79M 132.79M 45.16M 31.99M -170.76M -145.01M -141.13M -135.04M -99.18M -98.4M -73.95M
Capital Expenditures
560.9K 237.55K -2.45K -837.08K -2.38M -2.41M -2.86M -5.83M -7.04M -6.31M -7.73M -5.04M -4.62M -5.4M -3.41M -2.98M -1.65M -1.72M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-643.35K -648K -648K -648K -4.66K n/a n/a -8.3M -8.3M -8.3M -10.41M -5.57M -5.57M -5.57M -3.58M -2.03M -2.03M -2.03M
Investing Cash Flow
-219.45K -547.45K -650.45K -1.49M -2.39M -2.41M -2.86M -5.83M -7.04M -6.31M -7.73M -5.04M -4.62M -5.4M -3.41M -2.98M -1.65M -1.72M
Debt Repayment
15M 15M n/a -20M n/a n/a -27.36M -10.36M -32.36M -32.36M -5M -2M n/a n/a 46.6M 46.6M 46.6M 46.6M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-14.76M 567.00 567.00 748.55K 825.12K 881.49K 881.49K 191.38K 911.92K 1.07M 1.41M 1.6M 1M 825K 902K 1.94M 2.4M 87.93M
Financial Cash Flow
1.3M 18.43M 5.42M -12.7M 8.45M 6.14M -23.41M -7.66M -30.72M -30.56M -2.86M -397K 1.51M 1.34M 48.02M 210.99M 397.52M 483.04M
Net Cash Flow
-63.86M -71.45M -54.98M -54.74M -43.14M 35.48M -24.84M 129.29M 95.03M 8.3M 21.41M -176.2M -148.11M -145.19M -90.43M 108.82M 297.46M 407.37M
Free Cash Flow
-64.67M -89.09M -59.75M -60.84M -70.74M 9.89M -20.88M 136.96M 125.75M 38.85M 24.27M -175.8M -149.63M -146.53M -138.45M -102.16M -100.06M -75.67M